NCT05423678 Clinical Trial - Analyzing Participation Experiences Of Amyotrophic Lateral Sclerosis Patients Status NOT_YET_RECRUITING Phase N/A
NCT05407428 A Prospective Study to Evaluate the Correlation Between Oculometric Measurements and Clinical Endpoints in ALS Patients Status COMPLETED Phase N/A
NCT05407324 Dazucorilant in Patients With Amyotrophic Lateral Sclerosis Status RECRUITING Phase PHASE2
NCT05404867 Study of Structural and Functional Brain Connectivity Changes in ALS (CoALS-II) Status COMPLETED Phase NA
NCT05358431 Stratification of Presymptomatic Amyotrophic Lateral Sclerosis: the Development of Novel Imaging Biomarkers Status RECRUITING Phase NA
NCT05357950 A Phase IIb, Multi-Center, Multinational, Double-Blind, Placebo-Controlled Study, With an Open Label Extension, to Evaluate Safety, Tolerability and Efficacy of PrimeC in Subjects With ALS Status COMPLETED Phase PHASE2
NCT05352958 Contribution of Diaphragmatic Ultrasound for Monitoring Diaphragmatic Function in Patients With Amyotrophic Lateral Sclerosis Status RECRUITING Phase N/A
NCT05349721 Study to Assess the Effects of PTC857 Treatment in Participants With Amyotrophic Lateral Sclerosis ALS Status TERMINATED Phase PHASE2
NCT05328492 Volume Mode Non-invasive Ventilation in Amyotrophic Lateral Sclerosis Status UNKNOWN Phase NA
NCT05306457 CNS10-NPC-GDNF Delivered to the Motor Cortex for ALS Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05299658 An Open-Label Extension for the Phase 2 Study in Early Symptomatic Amyotrophic Lateral Sclerosis Patients on Stable Background Therapy to Assess Bioenergetic Catalysis With CNM-Au8 to Slow Disease Progression in ALS Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05297487 Evaluation of the Early Use of the Pressure Relaxer in the Respiratory Impairment of Patients With Amyotrophic Lateral Sclerosis: Multicenter Randomized Controlled Study. Status NOT_YET_RECRUITING Phase NA
NCT05286372 An Intermediate Size Expanded Access Protocol of AMX0035 for ALS Status APPROVED_FOR_MARKETING Phase N/A
NCT05281484 Two Intermediate Expanded Access Protocols (EAP) CNMAu8.EAP01 and CNMAu8.EAP02 for ALS Status NO_LONGER_AVAILABLE Phase N/A
NCT05279755 A Study to Evaluate the Safety and Pharmacokinetics of Single and Multiple Doses of Prosetin in Healthy Volunteers and Participants With ALS Status ACTIVE_NOT_RECRUITING Phase PHASE1